Vama Lifecare Private Limited — Cyclophosphamide Exporter Profile
Indian Pharmaceutical Exporter · #8 for Cyclophosphamide · $204.4K export value · DGFT Verified
Vama Lifecare Private Limited is the #8 Indian exporter of Cyclophosphamide with $204.4K in export value and 21 verified shipments. Vama Lifecare Private Limited holds a 1.1% market share in Cyclophosphamide exports across 6 countries. The company exports 14 pharmaceutical products worth $1.4M across 3 therapeutic categories.
Vama Lifecare Private Limited — Cyclophosphamide Export Profile: Buyers & Destinations
Where Does Vama Lifecare Private Limited Export Cyclophosphamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED ARAB EMIRATES | $168.0K | 6 | 98.5% |
| TURKEY | $924 | 1 | 0.5% |
| MEXICO | $609 | 2 | 0.4% |
| KENYA | $489 | 3 | 0.3% |
| GHANA | $396 | 7 | 0.2% |
| SRI LANKA | $109 | 2 | 0.1% |
Vama Lifecare Private Limited exports Cyclophosphamide to 6 countries. The largest destination is UNITED ARAB EMIRATES accounting for 98.5% of Vama Lifecare Private Limited's Cyclophosphamide shipments, followed by TURKEY (0.5%) and MEXICO (0.4%). These destinations reflect Vama Lifecare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cyclophosphamide from Vama Lifecare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE | UNITED ARAB EMIRATES | $168.0K | 5 |
| AS PER INVOICE | KENYA | $1.4K | 7 |
| AS PER INVOICE MEXICO | MEXICO | $609 | 2 |
| EXP CODE E00211PSG COURIER SERVICE LIMITED | GHANA | $170 | 2 |
| AS PER INVOICE KENYA | KENYA | $159 | 1 |
| EXP CODE | SRI LANKA | $109 | 2 |
| AS PER INVOICE GHANA | GHANA | $99 | 2 |
Vama Lifecare Private Limited supplies Cyclophosphamide to 7 buyers globally. The largest buyer is TO THE (UNITED ARAB EMIRATES), followed by AS PER INVOICE (KENYA) and AS PER INVOICE MEXICO (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cyclophosphamide Export Value and How Much Does Vama Lifecare Private Limited Contribute?
India exported $4.6M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. Vama Lifecare Private Limited contributes $204.4K to this total, accounting for 1.1% of India's Cyclophosphamide exports. Vama Lifecare Private Limited ships Cyclophosphamide to 6 countries through 7 buyers.
What Is the Average Shipment Value for Vama Lifecare Private Limited's Cyclophosphamide Exports?
Vama Lifecare Private Limited's average Cyclophosphamide shipment value is $9.7K per consignment, based on 21 shipments totaling $204.4K. The largest destination is UNITED ARAB EMIRATES (98.5% of Vama Lifecare Private Limited's Cyclophosphamide exports).
How Does Vama Lifecare Private Limited Compare to Other Indian Cyclophosphamide Exporters?
Vama Lifecare Private Limited ranks #8 among 259 Indian Cyclophosphamide exporters with a 1.1% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($1.1M), ALEMBIC PHARMACEUTICALS LIMITED ($850.4K), CIPLA LIMITED ($550.0K). Vama Lifecare Private Limited processed 21 shipments to 6 destination countries.
What Cyclophosphamide Formulations Does Vama Lifecare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ CYCLOPHOSPHAMIDE 500 MG USP BATCH NO23BCP01 MFG DT FEB 23 EXP DT JAN 25 | $50.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ CYCLOPHOSPHAMIDE 500 MG USP BATCH NO23ACP01 MFG DT JAN 23 EXP DT DEC 24 | $50.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ CYCLOPHOSPHAMIDE 500 MG USP BATCH NO23BCP02 MFG DT FEB 23 EXP DT JAN 25 | $50.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS CYCLOPHOSPHAMIDE 50 MG BATCH NO 23BCT02 MFG DT FEB 23 EXP DT JAN 25 | $9.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS CYCLOPHOSPHAMIDE 50 MG BATCH NO 23BCT01 MFG DT FEB 23 EXP DT JAN 25 | $9.0K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCYCLOPHOSPHAMIDE TABLETS IP 50MG BATCH NO. CWZ1113 MFG DATE. 08/2023 EXPNOS | $924 | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION CYCLOPHOSPHAMIDE INJECTIONIP 1000MG BATCH NUMBER CM1025001B MANU | $341 | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTION CYCLOPHOSPHAMIDE INJECTIONIP 500MG BATCH NUMBER CYPB2436G MANUFA | $268 | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ.CYCLOPHOSPHAMIDE 1G BATCH NO. 23ICP01 MFG DATE. 09/2023 EXP DATE. 08 | $200 | 1 |
| * HARMLESS MEDICINE FOR HUMAN CONSUMPTION CYCLOPHOSPHAMIDE INJECTIONIP 1000MG BATCH NUMBER.: 24ICP03 MANUFAC | $159 | 1 |
Vama Lifecare Private Limited exports 21 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE FOR HUMAN CONSUMPTIONINJ CYCLOPHOSPHAMIDE with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Cyclophosphamide to Key Markets
What Vama Lifecare Private Limited must comply with to export Cyclophosphamide to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Vama Lifecare Private Limited Compare to Nearest Cyclophosphamide Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | GETWELL PHARMACEUTICALS | $241.8K | 94 | 9 | $2.6K |
| 7 | KWALITY PHARMACEUTICALS LIMITED | $235.6K | 19 | 4 | $12.4K |
| 8 | VAMA LIFECARE PRIVATE LIMITED ★ | $204.4K | 21 | 6 | $9.7K |
| 9 | 3S CORPORATION | $171.1K | 35 | 5 | $4.9K |
| 10 | VIVALIA REMEDIES PRIVATE LIMITED | $147.8K | 4 | 1 | $37.0K |
Vama Lifecare Private Limited ranks #8 among 259 Indian Cyclophosphamide exporters. Average shipment value of $9.7K compared to the market average of $17.9K. The closest competitors by value are GETWELL PHARMACEUTICALS and KWALITY PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Cyclophosphamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 561 | 26.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 442 | 20.9% |
| DELHI AIR | 246 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 189 | 8.9% |
| Bombay Air | 154 | 7.3% |
| Delhi Air | 51 | 2.4% |
| Bombay Air Cargo | 51 | 2.4% |
| HYDERABAD AIR | 36 | 1.7% |
What Other Oncology Products Does Vama Lifecare Private Limited Export?
Vama Lifecare Private Limited also exports these oncology products. Each links to the detailed product page.
About Vama Lifecare Private Limited
Vama Lifecare Private Limited exports 14 products worth $1.4M. Beyond Cyclophosphamide, top products include Daratumumab, Ibrutinib, Pembrolizumab, Ustekinumab, Cetuximab. View the complete Vama Lifecare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Vama Lifecare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 21 individual customs records matching Vama Lifecare Private Limited exporting Cyclophosphamide, covering 21 formulations to 6 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Export Data from Vama Lifecare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Vama Lifecare Private Limited's Cyclophosphamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Vama Lifecare Private Limited
Full Company Profile →
14 products · $1.4M total trade · 3 categories
Cyclophosphamide Stats
Company Overview
Top Products by Vama Lifecare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Vama Lifecare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current shipment-level data, contact TransData Nexus.